Literature DB >> 3264909

Partial purification of a major type of rat prostatic growth factor: characterization as an epidermal growth factor-related mitogen.

N Nishi1, Y Matuo, F Wada.   

Abstract

The dorsolateral prostate of rats contains a mitogen that shares several properties with epidermal growth factor (EGF), which was designated as prostatic EGF-related mitogen (PEM). PEM was purified about 2,100-fold using molecular-sieve and ion-exchange chromatography. Final preparation stimulated DNA synthesis in BALB/c 3T3 cells at a concentration as low as 1.5 ng/ml and competed with 125I-EGF for binding to cell surface receptors. PEM had a molecular weight of about 14,000 and an isoelectric point of about 4.5, being heat- and acid-stable but inactivated by dithiothreitol. The primary cultured rat dorsolateral prostate epithelial cells required EGF for maximum growth. Partially purified PEM fully substituted for EGF in the primary culture system at a concentration as low as 90 ng/ml. However, the activity of PEM was hardly suppressed by antimouse EGF antiserum. These findings suggest that PEM is a member of the EGF family but has a higher molecular weight (high molecular weight EGF).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264909     DOI: 10.1002/pros.2990130303

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  3 in total

Review 1.  Prostate gland: structure, functions and regulation.

Authors:  V L Kumar; P K Majumder
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

2.  EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells.

Authors:  T Turner; P Chen; L J Goodly; A Wells
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

3.  Collagen-binding growth factors: production and characterization of functional fusion proteins having a collagen-binding domain.

Authors:  N Nishi; O Matsushita; K Yuube; H Miyanaka; A Okabe; F Wada
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.